标题:The Recent Development of Farnesyltransferase Inhibitors as Anticancer and Antimalarial Agents
作者:Shen, Yan;Qiang, Shengsheng;Ma, Shutao
作者机构:[Shen, Y] Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong U 更多
通讯作者:Ma, ST
通讯作者地址:[Ma, ST]Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, 44 West Culture Rd, Jinan 250012, Peoples R China.
来源:Mini reviews in medicinal chemistry
出版年:2015
卷:15
期:10
页码:837-857
DOI:10.2174/1389557515666150511152433
关键词:Anticancer;antimalaria;farnesyltransferase;FTase inhibitors;FTase inhibitory activity;selectivity
摘要:Cancer is a serious disease characterized by the uncontrolled growth division of cells, and nowadays it remains a significant challenge for the medical field. Malaria is an infectious disease in the similar situation to cancer. Almost 40% people in the world live in areas with malaria risk and each year there are about 2 to 3 million people dying from malaria. Farnesyltransferase (FTase) that belongs to isoprenyltransferase family can catalyze the initial step of Ras-processing and is identified as a promising target for the treatment of cancer and malaria. During the past decade years, a large number of FTase inhibitors with anticancer or antimalarial activity have been reported and some of them are undergoing clinical development. This review mainly introduces the FTase inhibitors as anticancer and antimalarial agents, with focus on their enzyme inhibitory activity, stability and enzyme selectivity, etc. In particular, the promising new FTase inhibitors among them will be discussed in detail and the inspirations for their design will be highlighted.
收录类别:SCOPUS;SCIE
WOS核心被引频次:5
Scopus被引频次:5
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84934767766&doi=10.2174%2f1389557515666150511152433&partnerID=40&md5=b983898e8d03b4d046ad9278d23076f0
TOP